Picture of Benitec Biopharma logo

BNTC — Benitec Biopharma Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Annual balance sheet for Benitec Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments4.062.4850.997.7180
Net Total Accounts Receivable
Net Total Receivables0.0030.0550.2290.0330.004
Prepaid Expenses
Total Other Current Assets
Total Current Assets4.823.7351.798.5182
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.9930.6130.4490.9910.871
Other Long Term Assets
Total Assets5.974.4652.299.6183
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities2.533.984.921.85.34
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities3.094.264.962.35.61
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity2.880.20247.297.3177
Total Liabilities & Shareholders' Equity5.974.4652.299.6183
Total Common Shares Outstanding